Mirae Asset Global Etfs Holdings Ltd. Candel Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 10,825 shares of CADL stock, worth $49,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,825Holding current value
$49,578% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
56Shares Held
6.41MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$8.86 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$4.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$3.77 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$2.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$2.06 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $132M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...